Aurgalys Team
Selected Customers
Home
Interim Management
Quantum Genomics [ALQGC]
Corporate Finance
Management Assistance
Due Diligence
Interim Management
Investor Assistance
Onxeo [ONXEO]
Diaxonhit [ALEHT]
 

May 4th, 2018 – Aurgalys, Listing Sponsor Euronext, is pleased to announce the listing of Parx Plastics on Euronext Access Paris. Parx Plastics is a Netherlands company specialized in antimicrobial plastics

mai 07, 2018

Paris- Evry, France, May 4th, 2018– Aurgalys, a global provider and Listing Sponsor for life sciences and healthcare companies through corporate finance, business development, and equity research services, announces the successful listing of Parx Plastics NV [ISIN code: NL0012650535; Ticker: MLPRX] on Euronext Access Paris through a private placement.

Parx Plastics N.V. is a Netherlands based company which has developed and patented an innovative technology to make plastics antimicrobial by making use of an essential nutrient. The integration of a body’s own trace element in plastics, results in a defence mechanism against bacteria reducing the number of bacteria on the surface by 99% and higher.

The antimicrobial plastic market size, in terms of value, is projected to reach EURO 13.75 billion by 2020, at a CAGR of 8.7%, between 2015 and 2020. Healthcare is accounting for more than one-third share of the market and is the key application of antimicrobial plastic, followed by packaging and consumer goods.

The technology is derived from biomimicry with the aim to develop a safe and biocompatible antimicrobial solution. By integrating an essential nutrient in existing raw materials a defence mechanism is created protecting the material against bacteria, molds, fungi and biofilm. The technology results in an antimicrobial effect of 99% and higher when tested according to international norm ISO22196 for the measurement of antibacterial activity on plastics.

The biocompatibility and the fact that the technology does not rely on leaching make it a unique solution that can be safely used for food contact application (e.g. food packaging) and for medical applications (e.g. implants).

Parx Plastics shares are being listed on Euronext Access™ Paris stock exchange through a private placement procedure. The issued share capital of Parx Plastics currently comprises of 6,810,582 shares. Based on a price per share of € 3.57 at the time of listing, the company’s market capitalization is € 24.3 million.

Comments are closed.